Pulmatrix's Grant - III Round

Pulmatrix raised a round of funding on December 14, 2010. Investors include DARPA.

Pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. The platform, called iSPERSE (inhaled small particles easily…

Articles about Pulmatrix's Grant - III Round: